Block Listing Interim Review

RNS Number : 6724P

Futura Medical PLC

30 May 2018

 

30 May 2018

Futura Medical plc

("Futura" or "the Company")

Block Listing Interim Review

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology today makes the following update on its block listings, pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies. All figures relate to options over Ordinary Shares.

The table below provides further detail. The figures include the block admission of 1,190,000 ordinary shares on 30 May 2018, as announced on 25 May 2018.

Name of company:	Futura Medical plc
Name of scheme(s):	Unapproved Share Option Scheme ("USOS") EMI Share Option Scheme ("EMI")
Period of return:	From:	25 November 2017
	To:	30 May 2018
Number and class of securities not issued under the scheme(s) at beginning of period	USOS:	2,396,110
	EMI:	2,671,390
	Total:	5,067,500
Number and class of securities admitted to the scheme(s) in the period	USOS:	400,000
	EMI:	790,000
	Total:	1,190,000
Number of securities issued under the scheme(s) during the period Number of securities lapsed under the scheme(s) during the period	USOS:	(150,000)
	EMI: USOS: EMI:	(160,000) (302,145) (457,855)
Balance of securities under the scheme(s) not yet issued at the end of the period	USOS:	2,343,965
	EMI:	2,843,535
	Total:	5,187,500
Number and class of securities originally admitted and the date of admission	USOS:	814,424 on 25 May 2011, 1,202,280 on 8 October 2013, 1,466,208 on 25 May 2017,    400,000 on 30 May 2018
	USOS Total:	3,882,912
	EMI:	1,520,576 on 25 May 2011, 1,467,720 on 8 October 2013, 1,893,792 on 25 May 2017,    790,000 on 30 May 2018
	EMI Total:	5,672,088
	Total:	9,555,000
Name of contact:	Angela Hildreth, Finance Director/COO
Telephone number of contact:	[phone]

For further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
Email to: [e-mail]	www.futuramedical.com
N+1 Singer (Nominated Adviser and Broker)
Aubrey Powell / Liz Yong Corporate Finance	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Sophie Cowles / Stephanie Watson	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com 

 

END

 

 

BLRGCGDUSBXBGIG